6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 6 of 6 clinical reviews.
Evidence-based guide to liraglutide dosing considerations for Black and African ancestry patients, including pharmacogenomic factors, clinical trial subgroup data, and titration protocols.
A clinically detailed review of liraglutide dosing in East Asian patients, covering pharmacokinetics, ethnicity-stratified trial data, BMI thresholds, and pharmacogenomic considerations including CYP2C19 and CYP2D6 polymorphisms.
Evidence-based review of liraglutide response differences in Black and African ancestry populations, including ethnicity-stratified trial data, pharmacogenomic factors, and clinical dosing guidance.
Evidence-based review of how liraglutide safety, pharmacogenomics, and dosing considerations differ for Hispanic and Latino populations, with ethnicity-stratified trial data and clinical guidance.
A clinician-reviewed guide to liraglutide dosing for South Asian patients, covering ethnicity-stratified trial data, pharmacogenomics, cardiovascular risk at lower BMI, and practical titration protocols.
South Asian patients face higher cardiovascular risk at lower BMI, earlier diabetes onset, and distinct pharmacogenomic variation. This clinical review covers liraglutide efficacy, safety signals, and dosing considerations specific to South Asian populations, with citations to ethnicity-stratified trial subgroups and guideline recommendations.